Raymond James Financial Inc. Purchases New Stake in Humana Inc. (NYSE:HUM)

Raymond James Financial Inc. acquired a new position in Humana Inc. (NYSE:HUM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 105,313 shares of the insurance provider’s stock, valued at approximately $26,720,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Pinnacle Wealth Management Advisory Group LLC boosted its stake in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. boosted its stake in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after acquiring an additional 38 shares during the last quarter. Mather Group LLC. grew its holdings in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock worth $60,000 after acquiring an additional 41 shares during the period. Capital Advisors Ltd. LLC grew its holdings in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 43 shares during the period. Finally, Retirement Planning Co of New England Inc. raised its position in shares of Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after acquiring an additional 43 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 7.4 %

Humana stock opened at $264.41 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a fifty day simple moving average of $265.75 and a 200 day simple moving average of $269.97. The company has a market cap of $31.91 billion, a P/E ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana’s payout ratio is presently 35.58%.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Truist Financial upped their price target on Humana from $290.00 to $325.00 and gave the company a “hold” rating in a research note on Friday, April 11th. Robert W. Baird lifted their price objective on shares of Humana from $270.00 to $300.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Barclays upped their target price on shares of Humana from $270.00 to $322.00 and gave the company an “equal weight” rating in a research note on Friday, April 11th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and an average target price of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.